Developer docs
API playgroundTry for free, no card

Search company profiles

R-Crio

Full company profile

uuid000jmxa

Namestring
R-Crio
Legal namestring
R-Crio Criogenia S/A
Websiteurl
r-crio.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

R-Crio Criogenia S/A is a Brazilian biotechnology company founded in 2014 and headquartered at Rua Cumarú 204, Alphaville Empresarial, Campinas, São Paulo. The company operates a specialized laboratory (CNPJ 19.208.189/0001-30) focused on the collection, processing, multiplication, quality testing, and long-term cryopreservation of mesenchymal stem cells at -196°C in liquid nitrogen. Cell sources include deciduous teeth, wisdom teeth, adipose tissue, and palate tissue. Its customer base spans families with children seeking biological insurance for future regenerative use, adults pursuing preventive medicine, athletes recovering from orthopedic injuries, and individuals with hereditary disease risk profiles. The company holds nine international patents, has published 50 scientific articles, and authored eight books on regenerative medicine and odontology; founder José Ricardo Muniz Ferreira leads the firm, which is privately held with no disclosed outside investors.

The business model blends three revenue streams: subscription-based stem cell storage contracts delivered through R-Crio Plans (which include personalized cell multiplication, credentialed collector consultations, transport logistics, and issuance of a Cryopreservation Certificate), one-time course fees from R-Crio Educacional (an online platform offering two- to 16-hour certified courses in regenerative medicine, gene therapy, biomaterials, and project management priced from free to R$1,599 with installment options), and franchise royalties from three domestic franchise units in Londrina/PR, Mogi das Cruzes/SP, and São Caetano do Sul/SP. Distribution runs exclusively through a Brazilian network of credentialed dentists and doctors, with samples shipped to the Campinas laboratory for processing. The company holds ANVISA Cell Processing Center licensing aligned with RDC 505/2021, RDC 506/2021, and RDC 836/2023, positioning it for the regulated advanced therapy market.

Beyond core storage services, R-Crio is advancing R-Angio-Crio, an Advanced Therapy Product (PTA) using mesenchymal stem cells for neuroprotection, angiogenesis, and inflammatory modulation, which was in pre-clinical development as of 2025 with a stated path toward clinical evaluation. Operations remain entirely domestic (Southeast Brazil) with no international footprint, 11-50 employees, and founder-controlled ownership. Marketing leans on organic social (Instagram, LinkedIn, YouTube), content marketing through the company blog, an educational platform, WhatsApp for bottom-of-funnel conversions, email newsletters, and a customer referral program offering a 5% discount on annual fees.

Short descriptiontext

R-Crio Criogenia S/A is a Brazilian biotechnology company, founded in 2014 in Campinas, that cryopreserves mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate at -196°C. It serves families and adults seeking preventive regenerative medicine and healthcare professionals seeking credentialed collection partnerships and certified education via R-Crio Educacional.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCampinas, Brazil
HQ citystring
Campinas
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
stem cell banking, cryopreservation services, regenerative medicine, biotechnology laboratory, advanced therapy products
NAICS code3 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Stem Cell Cryopreservation Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Stem Cell Cryopreservation Services
TypeSubscription Recurring
Description

Collection, processing, multiplication, quality testing, and long-term cryopreservation of mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate for personal health planning.

r-crio.com
2Educational Courses (R-Crio Educacional)
TypeOne Time License
Description

Online courses for healthcare professionals on regenerative medicine, stem cell therapies, gene therapy, biomaterials, and project management. Courses range from 2 to 16 hours with certification.

med.r-crio.com
3Franchise Units
TypeSubscription Recurring
Description

Licensed franchise operations in Brazil where franchisees operate their own R-Crio branded collection points with their own collection kits and local patient prospecting.

r-crio.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain
Pricing details6 tiers
1Células-tronco: Fundamentos e aplicações - 2 hour course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

R$199.00 upfront or 12x of R$16.58

med.r-crio.com
2Medicina regenerativa e Engenharia Tecidual - 2 hour course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Free access

med.r-crio.com
3Potencial terapêutico de células mesenquimais para lesão da medula espinhal - 2 hour course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Free access

med.r-crio.com
4Biomateriais e suas Aplicações em Medicina Regenerativa - 2 hour course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

R$199.00 upfront

med.r-crio.com
5Fundamentos da Gestão de Projetos - 8 hour course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

R$799.00 upfront or 12x of R$66.58

med.r-crio.com
6Terapia Gênica - 16 hour course
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

R$1,599.00 upfront or 12x of R$133.25

med.r-crio.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

R-Crio operates a biotechnology laboratory in Campinas, Brazil that collects, processes, multiplies, and cryopreserves mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate at -196°C in liquid nitrogen for long-term personal storage. Customers contract R-Crio Plans that bundle personalized cell multiplication, credentialed collector consultations, sample transport, quality testing, and a Cryopreservation Certificate. The company also runs R-Crio Educacional, an online platform selling certified courses in regenerative medicine, gene therapy, and biomaterials to healthcare professionals.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Cryopreservation maintains stem cells at the patient's biological age, allowing future cell formation from younger cells while the body ages normally
Product overview1 text field

R-Crio is a Brazilian biotechnology company specializing in stem cell storage and cryopreservation services. The core offering consists of collection, processing, multiplication, and cryopreservation of mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate at -196°C in liquid nitrogen. Services are delivered through R-Crio Plans, which include personalized stem cell multiplication, credentialed professional consultations, transport logistics, and certification. The company operates R-Angio-Crio, an Advanced Therapy Product (PTA) in pre-clinical development for neuroprotection and angiogenesis. R-Crio also operates R-Crio Educacional, an educational platform offering professional courses in regenerative medicine, gene therapy, biomaterials, and related topics, with franchise opportunities available for health professionals.

Product and service2 records
1Stem Cell Storage and Cryopreservation Services (R-Crio Plans)
CategoryCore cryopreservation service
Description

End-to-end stem cell cryopreservation service sold to individual consumers and families: collection consultation with a credentialed dentist or doctor, sample transport to the Campinas laboratory, processing and personalized multiplication of mesenchymal stem cells, post-multiplication therapeutic quality testing, and long-term storage in liquid nitrogen at -196°C. Customers receive a Cryopreservation Certificate, Client Portal access, and ongoing newsletter updates; contract structure includes recurring annual storage fees.

2R-Crio Educacional
CategoryProfessional education and certification
Description

Online continuing-education platform for healthcare professionals (doctors, dentists, biomedics, biochemists, nurses, biologists, biotechnologists) offering 2- to 16-hour certified courses in regenerative medicine, stem cell therapies, gene therapy, biomaterials in regenerative medicine, and project management fundamentals. Courses range from free modules to paid programs up to R$1,599 with 12-installment payment options and certification recognized in the global health sector.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Anadem's corporate university partners with R-Crio for educational content in regenerative medicine, with R-Crio Educacional providing specialized courses for Anadem members.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based stem cell banking company offering cord blood and tissue cryopreservation services. Directly comparable to R-Crio as a consumer-facing stem cell storage business with recurring storage revenue.

TypeBroad incumbent
Description

Listed regenerative medicine company commercializing mesenchymal stem cell therapies across multiple indications. Comparable to R-Crio as a mesenchymal stem cell platform with both ATMP development and broader regenerative medicine ambitions.

TypeDirect peer
Description

UK-based family stem cell bank offering cord blood, cord tissue and dental pulp stem cell storage. Comparable to R-Crio as a multi-source consumer stem cell storage service with international reach.

TypeDirect peer
Description

Brazil's largest private umbilical cord blood stem cell bank. Direct Brazilian peer to R-Crio, operating in the same domestic consumer stem cell banking market with similar clinician-driven distribution.

TypeDirect peer
Description

UK-based stem cell bank specializing in cryopreservation of stem cells from children's teeth. Closely mirrors R-Crio's core proposition of storing mesenchymal stem cells from deciduous teeth for future therapeutic use.

TypeDirect peer
Description

UK-based stem cell bank focused on cord blood and tissue storage. Comparable to R-Crio as a private, subscription-based stem cell storage business targeting expectant and family consumers.

TypeEmerging player
Description

Clinical-stage cell therapy company developing autologous mesenchymal stem cell therapies for neurodegenerative diseases. Comparable to R-Crio's R-Angio-Crio program as a mesenchymal stem cell-based therapeutic targeting neurological indications.

TypeBroad incumbent
Description

Long-established US family cord blood bank now part of a larger life sciences group. Comparable to R-Crio as a branded, consumer-facing family stem cell bank with recurring storage contracts.

TypeDirect peer
Description

UK stem cell bank offering cord blood and tissue storage services globally. Comparable to R-Crio as a family-focused cryopreservation service with recurring storage revenue.

TypeDirect peer
Description

UK-based stem cell storage provider offering a range of family banking services. Comparable to R-Crio as a multi-source, recurring-revenue stem cell bank serving families.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

R-Crio

Stem Cell Cryopreservation Servicesr-crio.com

R-Crio Criogenia S/A is a Brazilian biotechnology company, founded in 2014 in Campinas, that cryopreserves mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate at -196°C. It serves families and adults seeking preventive regenerative medicine and healthcare professionals seeking credentialed collection partnerships and certified education via R-Crio Educacional.

What R-Crio does

R-Crio Criogenia S/A is a Brazilian biotechnology company founded in 2014 and headquartered at Rua Cumarú 204, Alphaville Empresarial, Campinas, São Paulo. The company operates a specialized laboratory (CNPJ 19.208.189/0001-30) focused on the collection, processing, multiplication, quality testing, and long-term cryopreservation of mesenchymal stem cells at -196°C in liquid nitrogen. Cell sources include deciduous teeth, wisdom teeth, adipose tissue, and palate tissue. Its customer base spans families with children seeking biological insurance for future regenerative use, adults pursuing preventive medicine, athletes recovering from orthopedic injuries, and individuals with hereditary disease risk profiles. The company holds nine international patents, has published 50 scientific articles, and authored eight books on regenerative medicine and odontology; founder José Ricardo Muniz Ferreira leads the firm, which is privately held with no disclosed outside investors.

The business model blends three revenue streams: subscription-based stem cell storage contracts delivered through R-Crio Plans (which include personalized cell multiplication, credentialed collector consultations, transport logistics, and issuance of a Cryopreservation Certificate), one-time course fees from R-Crio Educacional (an online platform offering two- to 16-hour certified courses in regenerative medicine, gene therapy, biomaterials, and project management priced from free to R$1,599 with installment options), and franchise royalties from three domestic franchise units in Londrina/PR, Mogi das Cruzes/SP, and São Caetano do Sul/SP. Distribution runs exclusively through a Brazilian network of credentialed dentists and doctors, with samples shipped to the Campinas laboratory for processing. The company holds ANVISA Cell Processing Center licensing aligned with RDC 505/2021, RDC 506/2021, and RDC 836/2023, positioning it for the regulated advanced therapy market.

Beyond core storage services, R-Crio is advancing R-Angio-Crio, an Advanced Therapy Product (PTA) using mesenchymal stem cells for neuroprotection, angiogenesis, and inflammatory modulation, which was in pre-clinical development as of 2025 with a stated path toward clinical evaluation. Operations remain entirely domestic (Southeast Brazil) with no international footprint, 11-50 employees, and founder-controlled ownership. Marketing leans on organic social (Instagram, LinkedIn, YouTube), content marketing through the company blog, an educational platform, WhatsApp for bottom-of-funnel conversions, email newsletters, and a customer referral program offering a 5% discount on annual fees.

R-Crio firmographics

Firmographics
Name
R-Crio
Legal name
R-Crio Criogenia S/A
Website
https://r-crio.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
R-Crio Criogenia S/A is a Brazilian biotechnology company, founded in 2014 in Campinas, that cryopreserves mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate at -196°C. It serves families and adults seeking preventive regenerative medicine and healthcare professionals seeking credentialed collection partnerships and certified education via R-Crio Educacional.
Ownership category
akta.pro rank

Where R-Crio is headquartered

Location

Headquarters

HQ city
Campinas
HQ country
Brazil
HQ region
Latin America

Offices4 records

Markets served

R-Crio business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Stem Cell Cryopreservation Services: Collection, processing, multiplication, quality testing, and long-term cryopreservation of mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate for personal health planning.
  2. Educational Courses (R-Crio Educacional): Online courses for healthcare professionals on regenerative medicine, stem cell therapies, gene therapy, biomaterials, and project management. Courses range from 2 to 16 hours with certification.
  3. Franchise Units: Licensed franchise operations in Brazil where franchisees operate their own R-Crio branded collection points with their own collection kits and local patient prospecting.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goCélulas-tronco: Fundamentos e aplicações - 2 hour course
One time/ perpetual licensePay-as-you-goMedicina regenerativa e Engenharia Tecidual - 2 hour course
One time/ perpetual licensePay-as-you-goPotencial terapêutico de células mesenquimais para lesão da medula espinhal - 2 hour course
One time/ perpetual licensePay-as-you-goBiomateriais e suas Aplicações em Medicina Regenerativa - 2 hour course
One time/ perpetual licensePay-as-you-goFundamentos da Gestão de Projetos - 8 hour course
One time/ perpetual licensePay-as-you-goTerapia Gênica - 16 hour course

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

R-Crio product offering

Product offering

Core offering

R-Crio operates a biotechnology laboratory in Campinas, Brazil that collects, processes, multiplies, and cryopreserves mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate at -196°C in liquid nitrogen for long-term personal storage. Customers contract R-Crio Plans that bundle personalized cell multiplication, credentialed collector consultations, sample transport, quality testing, and a Cryopreservation Certificate. The company also runs R-Crio Educacional, an online platform selling certified courses in regenerative medicine, gene therapy, and biomaterials to healthcare professionals.

Product overview

R-Crio is a Brazilian biotechnology company specializing in stem cell storage and cryopreservation services. The core offering consists of collection, processing, multiplication, and cryopreservation of mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate at -196°C in liquid nitrogen. Services are delivered through R-Crio Plans, which include personalized stem cell multiplication, credentialed professional consultations, transport logistics, and certification. The company operates R-Angio-Crio, an Advanced Therapy Product (PTA) in pre-clinical development for neuroprotection and angiogenesis. R-Crio also operates R-Crio Educacional, an educational platform offering professional courses in regenerative medicine, gene therapy, biomaterials, and related topics, with franchise opportunities available for health professionals.

Differentiator

Problem solved

Functional benefit

Products and services

  • Stem Cell Storage and Cryopreservation Services (R-Crio Plans) End-to-end stem cell cryopreservation service sold to individual consumers and families: collection consultation with a credentialed dentist or doctor, sample transport to the Campinas laboratory, processing and personalized multiplication of mesenchymal stem cells, post-multiplication therapeutic quality testing, and long-term storage in liquid nitrogen at -196°C. Customers receive a Cryopreservation Certificate, Client Portal access, and ongoing newsletter updates; contract structure includes recurring annual storage fees.
  • R-Crio Educacional Online continuing-education platform for healthcare professionals (doctors, dentists, biomedics, biochemists, nurses, biologists, biotechnologists) offering 2- to 16-hour certified courses in regenerative medicine, stem cell therapies, gene therapy, biomaterials in regenerative medicine, and project management fundamentals. Courses range from free modules to paid programs up to R$1,599 with 12-installment payment options and certification recognized in the global health sector.

Quantifiable outcome

  • Cryopreservation maintains stem cells at the patient's biological age, allowing future cell formation from younger cells while the body ages normally

Companies that use R-Crio

Customer profile

Named customers2 records

Segments5 records

Ideal customer profiles4 records

R-Crio technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

R-Crio partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Universidade Corporativa da AnademminorStrategic or Co-development PartnerAnadem's corporate university partners with R-Crio for educational content in regenerative medicine, with R-Crio Educacional providing specialized courses for Anadem members.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

R-Crio competitors and assessment

Company assessment

Direct peers

  • Cryo-Cell International: US-based stem cell banking company offering cord blood and tissue cryopreservation services. Directly comparable to R-Crio as a consumer-facing stem cell storage business with recurring storage revenue.
  • Future Health Biobank: UK-based family stem cell bank offering cord blood, cord tissue and dental pulp stem cell storage. Comparable to R-Crio as a multi-source consumer stem cell storage service with international reach.
  • CordVida: Brazil's largest private umbilical cord blood stem cell bank. Direct Brazilian peer to R-Crio, operating in the same domestic consumer stem cell banking market with similar clinician-driven distribution.
  • Bioeden: UK-based stem cell bank specializing in cryopreservation of stem cells from children's teeth. Closely mirrors R-Crio's core proposition of storing mesenchymal stem cells from deciduous teeth for future therapeutic use.
  • Cells4Life: UK-based stem cell bank focused on cord blood and tissue storage. Comparable to R-Crio as a private, subscription-based stem cell storage business targeting expectant and family consumers.
  • Smart Cells International: UK stem cell bank offering cord blood and tissue storage services globally. Comparable to R-Crio as a family-focused cryopreservation service with recurring storage revenue.
  • Precious Cells: UK-based stem cell storage provider offering a range of family banking services. Comparable to R-Crio as a multi-source, recurring-revenue stem cell bank serving families.

Broad incumbents

  • Mesoblast: Listed regenerative medicine company commercializing mesenchymal stem cell therapies across multiple indications. Comparable to R-Crio as a mesenchymal stem cell platform with both ATMP development and broader regenerative medicine ambitions.
  • ViaCord: Long-established US family cord blood bank now part of a larger life sciences group. Comparable to R-Crio as a branded, consumer-facing family stem cell bank with recurring storage contracts.

Emerging players

  • BrainStorm Cell Therapeutics: Clinical-stage cell therapy company developing autologous mesenchymal stem cell therapies for neurodegenerative diseases. Comparable to R-Crio's R-Angio-Crio program as a mesenchymal stem cell-based therapeutic targeting neurological indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

R-Crio social profiles

Digital presence

R-Crio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

R-Crio leadership team

Management profile

Number of profiles

Profiles1 record

R-Crio funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

R-Crio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about R-Crio

What does R-Crio do?

R-Crio operates a biotechnology laboratory in Campinas, Brazil that collects, processes, multiplies, and cryopreserves mesenchymal stem cells from deciduous teeth, wisdom teeth, adipose tissue, and palate at -196°C in liquid nitrogen for long-term personal storage. Customers contract R-Crio Plans that bundle personalized cell multiplication, credentialed collector consultations, sample transport, quality testing, and a Cryopreservation Certificate. The company also runs R-Crio Educacional, an online platform selling certified courses in regenerative medicine, gene therapy, and biomaterials to healthcare professionals.

Is R-Crio a public or private company?

R-Crio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was R-Crio founded?

R-Crio was founded in 2014. It employs 11 to 50 people.

Where is R-Crio based?

R-Crio is headquartered in Campinas, Brazil, in the Latin America region.

How does R-Crio make money?

Three revenue lines are on record. Stem Cell Cryopreservation Services are the primary driver. The others are educational Courses (R-Crio Educacional) and franchise Units.

Who are R-Crio's main competitors?

Direct peers on record are Cryo-Cell International, Future Health Biobank, CordVida, Bioeden, Cells4Life, Smart Cells International and Precious Cells. Broad incumbents are Mesoblast and ViaCord. BrainStorm Cell Therapeutics is listed as an emerging player.

Does R-Crio have an API?

No public API is recorded for R-Crio.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales